Rare Disease Clinical Trials Market

Future Market Insights

Key Insight

The rare disease clinical trials market is projected to grow from USD 15.1 billion in 2025 to USD 38.2 billion by 2035, at a CAGR of 9.7%. Oncology will dominate with a 38.6% market share, while phase i will lead the phase outlook segment with a 33.2% share.

September 10, 2025

Anurag Sharma

342 Pages

Cite this Report

Rare Disease Clinical Trials Market

https://www.futuremarketinsights.com/reports/rare-disease-clinical-trials-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Charles River Laboratories
Covance Inc
F. Hoffmann-La Roche Ag
ICON plc
IQVIA
Novartis
PPD Inc.
Parexel International Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Rare Disease Clinical Trials Market

Key Players

Similar Industry Reports